Reps Pharmaceuticals
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimirep V 2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimirep V 2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimirep V 2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimirep V 2mg Tablet.
Glimirep V 2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimirep V 2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimirep V 2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimirep V 2mg Tablet is a combination medication containing Glimepiride, Metformin, and Voglibose. It's used to treat type 2 diabetes mellitus (DM). This medication improves blood sugar levels in adults when combined with a healthy diet and regular exercise. Glimepiride decreases blood glucose by increasing insulin release from the pancreas. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meal) glucose levels. It's not indicated for type 1 diabetes treatment.
Possible side effects associated with using Glimirep V 2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Patients with known allergies to any component of this medication or excipients (inactive ingredients) must avoid using it. It is also unsuitable for those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Glimirep V 2mg Tablet with alcohol is not recommended. It can lower blood sugar levels and increase the risk of lactic acidosis.
Yes, using Glimirep V 2mg Tablet can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. It's more likely to occur if you miss meals, drink alcohol excessively, over-exercise, or take other antidiabetic medications alongside it. Regular monitoring of blood sugar levels is essential. Always carry glucose tablets, honey, or fruit juice in case of sudden hypoglycemia.
Store this medication in its original packaging, tightly sealed. Follow the storage instructions on the label or the package. Do not discard it without consulting a healthcare professional. Keep the medicine out of reach of pets, children, and other people.